APP and Alzheimer disease: The type of E22Δ Aβ oligomers which cause neuronal degeneration and synaptic loss in AD patients with the Osaka APP mutations my either not be present in our model (see also discussion above on aggregation propensity of recombinant E22Δ Aβ) or it may appear in the wrong localization.